GIP and diabetes mellitus: In study of Finan et al., (2013) [90], unimolecular dual incretin was derived from an intermixed sequence of GLP-1 and GIP and administered into rodent models of obesity and diabetes and compared with placebo or equimolar doses of exendin-4.